Articles By Jack Cush, MD
Increased Risk of Depression and Anxiety in Rheumatoid Arthritis
Canadian researchers have analyzed population data and shown that the incidence and prevalence of depression, anxiety and bipolar disorders are elevated in the rheumatoid arthritis (RA) patients compared to a matched population.
Read Article
ACP Policy Calls for Increased Efforts in Women's Health Issues
The American College of Physicians have published a position paper in Annals of Internal Medicine calling for an examination of the challenges facing women in the U.S.
Read Article
The RheumNow Week in Review – Methotrexate CIRT Study (5.25.18)
Dr. Jack Cush reviews this past week's news from RheumNow.com - the risk of Cutaneous and Systemic LE, increasing flu vaccination, higher risk of VTE, MPO predictions, new drug for GIOP and CIRT - MTX in cardiovascular risk patients.
Read Article
Measures of Opioid Misuse Predict Future Opioid Overdose and Death
The current issue of Annals of Internal Medicine examines patterns of potential opioid misuse that are associated with subsequent adverse outcomes nationally.
Read Article
MPO Antibodies Predict Relapses in MPO-ANCA-Associated Vasculitis
A study of MPO-ANCA positive patients followed serially over 2 years shows that reappearance of MPO‐ANCA may predict relapse in patients with MPO‐ANCA positive AAV and that routine MPO‐ANCA monitoring is warranted.
Read Article
FDA Approves Denosumab for Glucocorticoid-Induced Osteoporosis
Amgen announced that the U.S.
Read Article
A Busted Valise
Just because it’s busted, it doesn’t mean you have to fix it. At some point, it’s important to know when to leave “good-enough” alone. Such is the story of the "busted valise" and what to do about it.
Read Article
ACR Leaders Lobby Capitol Hill for Help on Rising Costs and Access Barriers in Arthritis Care
Rheumatologists and rheumatology health professionals convened on Capitol Hill this week to urge legislative action on pressing policy issues affecting rheumatology care during the American College of Rheumatology’s Advocacy Leadership Conference, held May 16 -17, 2018 in Washington, D.C.
Read Article
The RheumNow Week in Review – Modifiable Behavior (5.18.18)
Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com. He discusses opioids, new approval for polyarticular JIA, running and osteoarthritis, and modifiable behaviors that influence outcomes.
Read Article
Treat-to-Target a Bust with Rheumatologists
Treat-to-target strategy is widely advocated as an important means of optimizing treatment responses in patients with rheumatoid arthritis. Even though T2T is encouraged by most guidelines, a current report shows that US Rheumatologists fail to implement T2T in their daily practice.
Read Article
